Therapeutic potential of kappa opioid agonists TC Beck, MA Hapstack, KR Beck, TA Dix Pharmaceuticals 12 (2), 95, 2019 | 65 | 2019 |
Descriptors of cytochrome inhibitors and useful machine learning based methods for the design of safer drugs TC Beck, KR Beck, J Morningstar, MM Benjamin, RA Norris Pharmaceuticals 14 (5), 472, 2021 | 32 | 2021 |
Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats TC Beck, CM Reichel, KL Helke, SS Bhadsavle, TA Dix European journal of pharmacology 856, 172396, 2019 | 30 | 2019 |
Mitral valve prolapse induces regionalized myocardial fibrosis JE Morningstar, C Gensemer, R Moore, D Fulmer, TC Beck, C Wang, ... Journal of the American Heart Association 10 (24), e022332, 2021 | 27 | 2021 |
Mitral Valve Prolapse and its Motley Crew‐Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition JE Morningstar, A Nieman, C Wang, T Beck, A Harvey, RA Norris Journal of the American Heart Association 10 (13), e020919, 2021 | 24 | 2021 |
Targeting peripheral κ-opioid receptors for the non-addictive treatment of pain TC Beck, TA Dix Future drug discovery 1 (2), FDD17, 2019 | 12 | 2019 |
Desert hedgehog-primary cilia cross talk shapes mitral valve tissue by organizing smooth muscle actin D Fulmer, KA Toomer, J Glover, L Guo, K Moore, R Moore, R Stairley, ... Developmental biology 463 (1), 26-38, 2020 | 10 | 2020 |
PDGFRα: expression and function during mitral valve morphogenesis K Moore, D Fulmer, L Guo, N Koren, J Glover, R Moore, C Gensemer, ... Journal of Cardiovascular Development and Disease 8 (3), 28, 2021 | 9 | 2021 |
The effects of pharmacological hypothermia induced by neurotensin receptor agonist ABS 201 on outcomes of CPR H Li, T Hua, W Wang, X Wu, C Miao, W Huang, Y Xiao, J Yang, JL Bradley, ... Shock 51 (5), 667-673, 2019 | 9 | 2019 |
DCHS1, Lix1L, and the septin cytoskeleton: molecular and developmental etiology of mitral valve prolapse KS Moore, R Moore, DB Fulmer, L Guo, C Gensemer, R Stairley, J Glover, ... Journal of Cardiovascular Development and Disease 9 (2), 62, 2022 | 6 | 2022 |
DZIP1 regulates mammalian cardiac valve development through a Cby1‐β‐catenin mechanism L Guo, T Beck, D Fulmer, S Ramos‐Ortiz, J Glover, C Wang, K Moore, ... Developmental Dynamics 250 (10), 1432-1449, 2021 | 6 | 2021 |
Cellular and Molecular Mechanisms of MEK1 Inhibitor–Induced Cardiotoxicity TC Beck, DC Arhontoulis, JE Morningstar, N Hyams, A Stoddard, ... Cardio Oncology 4 (4), 535-548, 2022 | 5 | 2022 |
Dynamic expression profiles of β-catenin during murine cardiac valve development L Guo, J Glover, A Risner, C Wang, D Fulmer, K Moore, C Gensemer, ... Journal of Cardiovascular Development and Disease 7 (3), 31, 2020 | 5 | 2020 |
The C-C Chemokine Receptor Type 4 is an Immunomodulatory Target of Hydroxychloroquine NRA Beck TC, Beck KR, Holloway CB, Hemings RA, Dix TA Frontiers in Pharmacology 11 (1253), 2020 | 5 | 2020 |
Diuretic activity of a novel peripherally-restricted orally-active kappa opioid receptor agonist TC Beck, MA Hapstack, GS Ghatnekar, TA Dix Medical Sciences 7 (9), 93, 2019 | 5 | 2019 |
Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs TC Beck, K Springs, JE Morningstar, C Mills, A Stoddard, L Guo, K Moore, ... Molecules 27 (12), 3678, 2022 | 2 | 2022 |
Biased Opioid Receptor Ligands: Gain without Pain TC Beck, TA Dix, RA Norris Trends Endocrinol Metab, 2020 | 2* | 2020 |
Targeting peripheral kappa opioid receptors for the treatment of chronic pain TC Beck, TA Dix, CM Reichel Advances in nanomedicine and nanotechnology research 1 (1), 16, 2019 | 2 | 2019 |
Immunoglobulin G4-related disease-associated dermatitis with pruritus: A positive response to dupilumab TC Beck, J Plante, I Robinson, K Khatskevich, JA Forcucci, M Valdebran Life 13 (3), 833, 2023 | 1 | 2023 |
Mitral valve prolapse induces regionalized left ventricular fibrosis JE Morningstar, C Gensemer, R Moore, DB Fulmer, T Beck, C Wang, ... Circulation 144 (Suppl_1), A9400-A9400, 2021 | 1 | 2021 |